Literature DB >> 16084225

Evaluation of disease severity in familial Mediterranean fever.

Adam Mor1, Yael Shinar, Nurit Zaks, Pnina Langevitz, Angela Chetrit, Shmuel Shtrasburg, Einat Rabinovitz, Avi Livneh.   

Abstract

OBJECTIVE: To establish a new, objective, statistically based severity score for familial Mediterranean fever (FMF).
METHODS: One hundred consecutive FMF patients were evaluated independently by 2 FMF experts for severity of their disease and were assigned to 1 of 3 severity levels: mild, intermediate, or severe. Nine candidate criteria, reflecting objective suffering and disability, were analyzed to determine their weight for patient placement in the 3 predefined severity groups.
RESULTS: Candidate criteria best differentiating between the 3 patient categories were the frequency of attacks, the number of sites affected during an attack and during the course of the disease, and the duration of the attacks. These criteria were applied in a classification-tree model to establish a new FMF-severity score (F-SS). The first set of F-SS (F-SS-1) was highly sensitive and specific. Integrating F-SS-1 with clinical parameters strongly associated with disease severity resulted in a simplified score, the second set of F-SS (F-SS-2).
CONCLUSIONS: New, useful, objective, and valid severity scores were established and found to distinguish between patients with mild, intermediate, and severe diseases with high sensitivity and specificity. RELEVANCE: The F-SS established may be important for treatment decisions, prognosis evaluation, and comparative analysis of patient populations.

Entities:  

Mesh:

Year:  2005        PMID: 16084225     DOI: 10.1016/j.semarthrit.2005.02.002

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  35 in total

1.  Diagnosis. Severity scoring system for paediatric FMF.

Authors:  Avi Livneh
Journal:  Nat Rev Rheumatol       Date:  2012-04-17       Impact factor: 20.543

2.  Risk factors for subclinical inflammation in children with Familial Mediterranean fever.

Authors:  Meral Torun Bayram; Tufan Çankaya; Elçin Bora; Salih Kavukçu; Ayfer Ülgenalp; Alper Soylu; Mehmet Türkmen
Journal:  Rheumatol Int       Date:  2015-02-11       Impact factor: 2.631

3.  Severity scoring system for paediatric FMF.

Authors:  Gokhan Kalkan; Erkan Demirkaya; Seza Ozen
Journal:  Nat Rev Rheumatol       Date:  2012-09-11       Impact factor: 20.543

4.  The factors considered as trigger for the attacks in patients with familial Mediterranean fever.

Authors:  Omer Karadag; Abdurrahman Tufan; Veli Yazisiz; Kemal Ureten; Sedat Yilmaz; Muhammet Cinar; Ali Akdogan; Hakan Erdem; Mehmet Akif Ozturk; Salih Pay; Ayhan Dinc
Journal:  Rheumatol Int       Date:  2012-07-20       Impact factor: 2.631

5.  Quality of life in adult patients with Familial Mediterranean fever living in Germany or Turkey compared to healthy subjects: a study evaluating the effect of disease severity and country of residence.

Authors:  Arnd Giese; Mustafa Kurucay; Levent Kilic; Ahmet Örnek; Süleyman Nahit Şendur; Elke Lainka; Bernhard Ferdinand Henning
Journal:  Rheumatol Int       Date:  2012-12-29       Impact factor: 2.631

6.  Familial Mediterranean fever: an association with non-alcoholic fatty liver disease.

Authors:  Doron Rimar; Itzhak Rosner; Michael Rozenbaum; Eli Zuckerman
Journal:  Clin Rheumatol       Date:  2011-03-02       Impact factor: 2.980

7.  Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activity.

Authors:  Sema Haliloglu; Ayse Carlioglu; Derya Akdeniz; Yasar Karaaslan; Ali Kosar
Journal:  Rheumatol Int       Date:  2014-03-04       Impact factor: 2.631

8.  Evaluation of the international severity score for FMF (ISSF) scores in Turkish children diagnosed with FMF: a single-center experience.

Authors:  Fatih Mehmet Akif Özdemir; Nesrin Gülez; Balahan Makay
Journal:  Clin Rheumatol       Date:  2021-02-22       Impact factor: 2.980

9.  Screening of common and novel familial mediterranean fever mutations in south-east part of Turkey.

Authors:  Serdar Oztuzcu; Mustafa Ulaşlı; Sercan Ergun; Yusuf Ziya Iğci; Mehri Iğci; Recep Bayraktar; Gülper Nacarkahya; Ali Tamer; Muammer Ozgür Cevik; Ecir Ali Cakmak; Ahmet Arslan
Journal:  Mol Biol Rep       Date:  2014-01-28       Impact factor: 2.316

Review 10.  [Evidence-based treatment recommendations for familial Mediterranean fever : A joint statement by the Society for Pediatric and Adolescent Rheumatology and the German Society for Rheumatology].

Authors:  T Kallinich; N Blank; T Braun; E Feist; U Kiltz; U Neudorf; P T Oommen; C Weseloh; H Wittkowski; J Braun
Journal:  Z Rheumatol       Date:  2019-02       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.